Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Licitra

Showing results (91-100 of 311) with videos related to

Pageof 32
Sort By:
Journal of the American Academy of Dermatology|October 16, 2012
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinomaPaolo Bossi, Carlo Resteghini, Federica Perrone, et al.
Oncology|September 4, 2024
Claudin-1 in Head and Neck Squamous Cell CarcinomaStefano Cavalieri, Cristiana Bergamini, Deborah Lenoci, et al.
Journal of Translational Medicine|October 13, 2017
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016Paolo A Ascierto, Bruno Daniele, Hans Hammers, et al.
Oral Oncology|January 14, 2021
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluationChiara Trevisiol, Massimo Gion, Alberto Vaona, et al.
BMC Public Health|October 14, 2025
Impact of head and neck cancer on the income of Italian employeesAlessandra Macciotta, Annalisa Trama, Alice Bernasconi, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
NMR in Biomedicine|February 4, 2020
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancerMarco Bologna, Giuseppina Calareso, Carlo Resteghini, et al.
Cancer Treatment Reviews|July 23, 2018
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancerJaume Capdevila, Kate Newbold, Lisa Licitra, et al.
International Journal of Cancer|April 12, 2021
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysisDaria Maria Filippini, Milo Gatti, Vito Di Martino, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV statusCarlo Fallai, Federica Perrone, Lisa Licitra, et al.
Pageof 32

Showing results (91-100 of 311) with videos related to

Sort By:
Pageof 32
Journal of the American Academy of Dermatology|October 16, 2012
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinomaPaolo Bossi, Carlo Resteghini, Federica Perrone, et al.
Oncology|September 4, 2024
Claudin-1 in Head and Neck Squamous Cell CarcinomaStefano Cavalieri, Cristiana Bergamini, Deborah Lenoci, et al.
Journal of Translational Medicine|October 13, 2017
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016Paolo A Ascierto, Bruno Daniele, Hans Hammers, et al.
Oral Oncology|January 14, 2021
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluationChiara Trevisiol, Massimo Gion, Alberto Vaona, et al.
BMC Public Health|October 14, 2025
Impact of head and neck cancer on the income of Italian employeesAlessandra Macciotta, Annalisa Trama, Alice Bernasconi, et al.
Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.
NMR in Biomedicine|February 4, 2020
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancerMarco Bologna, Giuseppina Calareso, Carlo Resteghini, et al.
Cancer Treatment Reviews|July 23, 2018
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancerJaume Capdevila, Kate Newbold, Lisa Licitra, et al.
International Journal of Cancer|April 12, 2021
Bone fracture as a novel immune-related adverse event with immune checkpoint inhibitors: Case series and large-scale pharmacovigilance analysisDaria Maria Filippini, Milo Gatti, Vito Di Martino, et al.
International Journal of Radiation Oncology, Biology, Physics|July 7, 2009
Oropharyngeal squamous cell carcinoma treated with radiotherapy or radiochemotherapy: prognostic role of TP53 and HPV statusCarlo Fallai, Federica Perrone, Lisa Licitra, et al.
Pageof 32